BSE · VISTAPH
Vista Pharmaceuticals Ltd.
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#3,579
of 5,004 stocks
🏆 New peak
▲ 741W
Peak #3,579 · 01 Oct 2026
Vista Pharmaceuticals Ltd. is a microcap company in the Healthcare space and has a subdued return on equity, has a widely-held ownership base, with promoters at just 21%, and is seeing revenue slip.
Market Cap
38.84 Cr
P/E Ratio
—
P/B Ratio
1.07
ROE
-33.10%
ROCE
-39.16%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | Rs 0 | Rs 0 | 2.42 Cr | 1.46 Cr |
| Net Profit | -98.59 L | -5.86 Cr | -2.32 Cr | -2.59 Cr |
| EPS | 0.16 | -0.91 | 0.41 | -0.42 |
| Operating Profit | -99.12 L | -7.25 Cr | -3.10 Cr | -3.64 Cr |
Shareholding pattern
Promoter
21.19%
Public
78.81%
PUBLIC BREAKDOWN
DII
0.02%
MF (within DII)
0.02%
Individuals
38.72%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 25 Jun 2015 | Other | Reduction of Capital |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.